{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T21:06:30Z","timestamp":1795035990848,"version":"4.10.2"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Heart Foundation of Australia Vanguard","award":["102206"],"award-info":[{"award-number":["102206"]}]},{"name":"Arthritis Australia\u2014Australian Rheumatology Association Project Grant"},{"name":"Scleroderma Victoria Project Grant"},{"name":"St Vincent\u2019s Hospital Research Endowment Fund Project Grant","award":["88371"],"award-info":[{"award-number":["88371"]}]},{"name":"The University of Melbourne Research Establishment Grant"},{"name":"Australian Government Research Training Program Scholarship"},{"name":"University of Melbourne Research Training Scholarship"},{"name":"National Health and Medical Research Council of Australia Investigator Grant","award":["GNT 1176538"],"award-info":[{"award-number":["GNT 1176538"]}]},{"name":"Australian National Heart Foundation Future Leader Fellowship","award":["102021"],"award-info":[{"award-number":["102021"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Cardiac complications of SSc are a leading cause of SSc-associated death. Cardiac imaging for identifying substrate abnormality may be useful in predicting risk of cardiac arrhythmias or future cardiac failure. The aim of this study was to quantify the burden of asymptomatic fibro-inflammatory myocardial disease using cardiac magnetic resonance imaging (CMR) and assess the relationship between asymptomatic myocardial fibrosis and cardiac arrhythmias in SSc.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Thirty-two patients with SSc with no documented history of pulmonary vascular or heart disease underwent CMR with gadolinium and 24-h ambulatory ECG. Focal myocardial fibrosis was assessed using post-gadolinium imaging and diffuse fibro-inflammatory myocardial disease quantified using T1- and T2-mapping. CMR results were compared with an age- and sex-matched control group.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Post-gadolinium focal fibrosis was prevalent in SSc but not controls (30% vs 0%, p\u2009&amp;lt;\u20090.01).. T1-mapping values (as a marker of diffuse fibrosis) were greater in SSc than controls [saturated recovery single-shot acquisition (SASHA): 1584\u2009ms vs 1515\u2009ms, P\u2009&amp;lt;\u20090.001; shortened Modified look locker sequence (ShMOLLI): 1218\u2009ms vs 1138\u2009ms, p\u2009&amp;lt;\u20090.001]. More than one-fifth (22.6%) of the participants had ventricular arrhythmias on ambulatory ECG, but no associations between focal or diffuse myocardial fibrosis and arrhythmias were evident.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In SSc patients without evidence of overt cardiac disease, a high burden of myocardial fibrosis and arrhythmias was identified. However, there was no clear association between focal or diffuse myocardial fibrosis and arrhythmias, suggesting CMR may have limited use as a screening tool to identify SSc patients at risk of future significant arrhythmias.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keac065","type":"journal-article","created":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T12:11:40Z","timestamp":1643371900000},"page":"4497-4502","source":"Crossref","is-referenced-by-count":37,"title":["Myocardial fibrosis and arrhythmic burden in systemic sclerosis"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4636-729X","authenticated-orcid":false,"given":"Laura","family":"Ross","sequence":"first","affiliation":[{"name":"Department of Medicine, The University of Melbourne at St Vincent\u2019s Hospital"},{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Fitzroy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Costello","sequence":"additional","affiliation":[{"name":"Sports Cardiology Laboratory, Baker Heart and Diabetes Institute , Melbourne"},{"name":"Department of Cardiology, St Vincent\u2019s Hospital , Fitzroy, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne at St Vincent\u2019s Hospital"},{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Fitzroy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan","family":"Hansen","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Fitzroy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniina","family":"Lindqvist","sequence":"additional","affiliation":[{"name":"Sports Cardiology Laboratory, Baker Heart and Diabetes Institute , Melbourne"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Stevens","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Fitzroy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne at St Vincent\u2019s Hospital"},{"name":"Department of Cardiology, St Vincent\u2019s Hospital , Fitzroy, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Prior","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne at St Vincent\u2019s Hospital"},{"name":"Department of Cardiology, St Vincent\u2019s Hospital , Fitzroy, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandana","family":"Nikpour","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne at St Vincent\u2019s Hospital"},{"name":"Department of Rheumatology, St Vincent\u2019s Hospital , Fitzroy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"La Gerche","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Melbourne at St Vincent\u2019s Hospital"},{"name":"Sports Cardiology Laboratory, Baker Heart and Diabetes Institute , Melbourne"},{"name":"Department of Cardiology, St Vincent\u2019s Hospital , Fitzroy, VIC, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"2022110207591149700_keac065-B1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2022110207591149700_keac065-B2","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1161\/01.CIR.53.3.483","article-title":"Myocardial lesions of progressive systemic sclerosis a cause of cardiac dysfunction","volume":"53","author":"Bulkley","year":"1976","journal-title":"Circulation"},{"key":"2022110207591149700_keac065-B3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12968-016-0289-3","article-title":"Cardiovascular magnetic resonance patterns of biopsy proven cardiac involvement in systemic sclerosis","volume":"18","author":"Krumm","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022110207591149700_keac065-B4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/rheumatology\/ket377","article-title":"Cardiac arrhythmias and conduction defects in systemic sclerosis","volume":"53","author":"Vacca","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"2022110207591149700_keac065-B5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12968-016-0308-4","article-title":"Cardiac T1 mapping and extracellular volume (ECV) in clinical practice: a comprehensive review","volume":"18","author":"Haaf","year":"2016","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022110207591149700_keac065-B6","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"72","author":"van den Hoogen","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"2022110207591149700_keac065-B7","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets & pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2022110207591149700_keac065-B8","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s10554-017-1134-y","article-title":"SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T","volume":"33","author":"Costello","year":"2017","journal-title":"Int J Cardiovasc Imaging"},{"key":"2022110207591149700_keac065-B9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-16-21","article-title":"Subclinical myocardial inflammation and diffuse fibrosis are common in systemic sclerosis \u2013 a clinical study using myocardial T1-mapping and extracellular volume quantification","volume":"16","author":"Ntusi","year":"2014","journal-title":"J Cardiovasc Magn Reson"},{"key":"2022110207591149700_keac065-B10","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.semarthrit.2019.06.013","article-title":"T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients","volume":"50","author":"Poindron","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"2022110207591149700_keac065-B11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/ehjci\/jeu167","article-title":"Early myocardial and skeletal muscle interstitial remodelling in systemic sclerosis: insights from extracellular volume quantification using cardiovascular magnetic resonance","volume":"16","author":"Barison","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2022110207591149700_keac065-B12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ijcard.2017.08.072","article-title":"Myocardial fibrosis detected by magnetic resonance in systemic sclerosis patients \u2013 Relationship with biochemical and echocardiography parameters","volume":"249","author":"Hrom\u00e1dka","year":"2017","journal-title":"Int J Cardiol"},{"key":"2022110207591149700_keac065-B13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3390\/diagnostics9040220","article-title":"Cardiovascular magnetic resonance identifies high-risk systemic sclerosis patients with normal echocardiograms and provides incremental prognostic value","volume":"9","author":"Markousis-Mavrogenis","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"2022110207591149700_keac065-B14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/diagnostics10050335","article-title":"The doubled-edged sword of T1-mapping in systemic sclerosis-a comparison with infectious myocarditis using cardiovascular magnetic resonance","volume":"10","author":"Markousis-Mavrogenis","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"2022110207591149700_keac065-B15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/art.41308","article-title":"Cardiac intravoxel incoherent motion diffusion-weighted magnetic resonance imaging with T1 mapping to assess myocardial perfusion and fibrosis in systemic sclerosis: association with cardiac events from a prospective cohort study","volume":"72","author":"Terrier","year":"2020","journal-title":"Arthritis Rheum"},{"key":"2022110207591149700_keac065-B16","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10741-018-9718-8","article-title":"Prognostic value of T1 mapping and extracellular volume fraction in cardiovascular disease: a systematic review and meta-analysis","volume":"23","author":"Zhuang","year":"2018","journal-title":"Heart Fail Rev"},{"key":"2022110207591149700_keac065-B17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10840-019-00655-3","article-title":"Premature ventricular complexes: diagnostic and therapeutic considerations in clinical practice: a state-of-the-art review by the American College of Cardiology Electrophysiology Council","volume":"57","author":"Gorenek","year":"2020","journal-title":"J Interv Card Electrophysiol"},{"key":"2022110207591149700_keac065-B18","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/rheumatology\/kez494","article-title":"Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS)","volume":"59","author":"Mavrogeni","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2022110207591149700_keac065-B19","first-page":"S48","article-title":"Primary myocardial involvement in systemic sclerosis: evidence for a microvascular origin","volume":"28","author":"Allanore","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"2022110207591149700_keac065-B20","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/rheumatology\/key430","article-title":"Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP","volume":"58","author":"Bissell","year":"2019","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keac065\/43782077\/keac065.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/11\/4497\/46747662\/keac065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/61\/11\/4497\/46747662\/keac065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T08:01:16Z","timestamp":1667376076000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/61\/11\/4497\/6524640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":20,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,2,8]]},"published-print":{"date-parts":[[2022,11,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keac065","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,2,8]]}}}